F-1: Alternative Protein Innovator Launches Public Offering Amidst Going Concern Warning

A deep-tech food company focused on 3D-printed alternative proteins is seeking to raise up to $5 million through a public offering of American Depositary Shares and warrants, despite its latest audit report indicating substantial doubt about its ability to continue as a going concern.

Summary

• The company, an Israeli deep-tech food company established in 2019, specializes in alternative protein machinery production, including 3D printers for meat and seafood analogs and hybrid meats.
• Its initial commercial offering focuses on 3D printers and plant-based ingredient blends for plant-based meat and fish analogs, which do not require the lengthy regulatory processes associated with cultivated meats.
• In September 2024, the company opened its first full-scale Demonstration Center, showcasing its MX200 and HD144 3D printers.
• It received purchase orders in September 2024 from Bondor Foods Ltd. for plant-based premixes for white fish and salmon patties, and in October 2024 from Wyler Farm Ltd. for plant-based beef premixes.
• In November 2024, a two-year R&D collaboration with UMAMI Bioworks established the feasibility of scalable 3D-printed cultivated fish products, with support from the Singaporean National Additive Manufacturing Innovation Cluster.
• In December 2024, a non-binding Memorandum of Understanding was signed with Vegefarm Co. Ltd., a Taiwanese food company, for the sale of the MX200 3D printer and accompanying raw materials, with support from the Industrial Technology Research Institute (ITRI) for market adaptation.
• The company is offering in a best-efforts public offering up to 2,857,142 American Depositary Shares (ADSs), each representing 500 ordinary shares, along with up to 2,857,142 common warrants to purchase ADSs.
• The assumed combined public offering price is $1.75 per ADS and Common Warrant, based on the Nasdaq closing price on July 9, 2025.
• Pre-Funded Warrants are also offered at $1.74 each (exercise price $0.01) for purchasers whose beneficial ownership would exceed 4.99% (or 9.99%) of outstanding ordinary shares.
• Common Warrants have an exercise price of $1.75 per ADS, are immediately exercisable, and expire on the fifth anniversary of issuance.
• Up to 200,000 Placement Agent Warrants will be issued, exercisable at $2.1875 per ADS (125% of offering price) and expiring five years from sales commencement.
• The offering is expected to terminate on August 10, 2025, unless terminated earlier by the company.
• The company's audit report for the year ended December 31, 2024, includes an explanatory paragraph indicating substantial doubt about its ability to continue as a going concern due to significant losses and negative cash flows from operations and an accumulated deficit.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the explicit 'going concern' warning from auditors, the 'best efforts' nature of the offering which provides no guarantee of sufficient capital, and the significant potential for dilution for existing shareholders. While there are positive developments in product and partnerships, the financial instability overshadows them.

Positives

• Successfully developed and commercialized two main types of 3D food printers: a meat printer for fibrous textures and a fish printer for flaky textures.
• Secured significant purchase orders for proprietary plant-based premixes from Bondor Foods Ltd. and Wyler Farm Ltd. in late 2024.
• Achieved a key R&D milestone in collaboration with UMAMI Bioworks, demonstrating the feasibility of scalable 3D-printed cultivated fish products.
• Signed a non-binding Memorandum of Understanding with Vegefarm Co. Ltd. for the sale of its MX200 3D printer and raw materials, indicating international market expansion.
• Led by an experienced CEO, Arik Kaufman, who has a background in foodtech and biotech, and has partnered with BlueOcean Sustainability Fund, LLC to accelerate growth.

Negatives

• The offering is on a 'best efforts' basis, meaning there is no guarantee that the company will sell all securities or raise the maximum intended capital.
• There is no minimum offering amount required as a condition to closing, which could result in significantly less proceeds than anticipated.
• The audit report for December 31, 2024, explicitly states that the company's 'significant losses and negative cash flows from operations and accumulated deficit raise substantial doubt about the entity's ability to continue as a going concern.'
• There is no established public trading market for the Common Warrants and Pre-Funded Warrants, and the company does not intend to list them, limiting their liquidity.
• Common Warrants may have no value if the market price of the ADSs does not exceed the exercise price of $1.75 per ADS during their five-year term.
• The company has never paid dividends and does not intend to do so in the foreseeable future, meaning investment returns depend solely on price appreciation.
• The company is subject to significant risks related to geopolitical and economic instability in Israel, including ongoing conflicts, cyber attacks, credit rating downgrades, military reservist call-ups, and potential international boycotts.

Risks

• Future equity offerings or other equity issuances may cause significant dilution to existing shareholders.
• The 'best efforts' offering structure means the company may not raise sufficient capital to support its operations or business plan, potentially leading to greater operating losses.
• Management has broad discretion over the use of net proceeds, and their decisions may not result in positive returns or align with shareholder expectations.
• Purchasers who enter into a securities purchase agreement in this offering may have superior rights and remedies compared to other purchasers.
• The sale of a substantial number of ADSs (up to 155% of outstanding Ordinary Shares prior to this offering) could materially adversely affect the price of the ADSs.
• There is no public market for the Common Warrants or Pre-Funded Warrants, limiting their liquidity and potential value.
• The Common Warrants may expire without value if the ADS market price does not exceed their exercise price.
• Holders of Pre-Funded Warrants and Common Warrants have no shareholder rights until their warrants are exercised.
• The company may be treated as a Passive Foreign Investment Company (PFIC) for U.S. federal income tax purposes, leading to adverse tax consequences for U.S. investors.
• U.S. persons owning 10% or more of the company's shares may be subject to adverse U.S. federal income tax consequences under Controlled Foreign Corporation rules.
• Conditions in Israel, including ongoing conflicts with Hamas, Hezbollah, and Iran, as well as political and economic instability, may adversely impact business operations, supply chains, and employee availability.
• The company's commercial insurance does not cover losses from war and terrorism, and government coverage may not be sufficient.
• Growing movements to boycott Israeli goods and services, along with potential international tribunal rulings against Israel, could negatively impact business operations.

Future Outlook

The company intends to use the net proceeds from the current offering for additional working capital, funding business growth, including potential re-purchase of its securities, and general corporate purposes. It aims to continue developing its alternative protein manufacturing technologies and expand commercial sales of its 3D printers and ingredient blends. The company is also pursuing the acquisition of Twine Solutions Ltd. to accelerate commercial expansion.

Management Comments

• Arik Kaufman, Chief Executive Officer, has founded various Nasdaqand TASE-traded foodtech companies and is a founding partner of BlueOcean Sustainability Fund, LLC, which has partnered with the company to accelerate growth. He holds extensive personal experience in food-tech and bio-tech, and has led numerous complex commercial negotiations.

Industry Context

The company operates in the rapidly evolving alternative protein and cultivated meat industry, aiming to address environmental impact, improve supply chains, and offer new product offerings. Its focus on 3D printing technology positions it at the intersection of food technology and advanced manufacturing, targeting both plant-based and cultivated protein markets.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• **February 2025 ELOC with Alumni Capital LP**: An $8 million equity line of credit, with a commitment fee of 34,934 ADSs paid to Alumni.
• **February 2025 Private Placement with Alumni Capital LP**: Alumni purchased 38,532 ADSs, warrants for 219,472 ADSs, and pre-funded warrants for 180,940 ADSs.
• **June 2025 Private Placement with Gefen Capital Investments LP**: Gefen, the controlling shareholder of Twine Solutions Ltd., purchased 124,286 ADSs for $870,000.
• **June 2025 Convertible Loan from D.B.W. Holdings (2005) Ltd.**: A $870,000 loan provided to the company, convertible into ADSs at $7.00 per ADS under certain conditions related to the Twine acquisition.
• **June 2025 Convertible Loan to Twine Solutions Ltd.**: The company provided a $1,740,000 convertible loan to Twine, which is the subject of a potential acquisition.

Stakeholder Impact

• **Shareholders**: Face significant potential dilution from the current offering and outstanding convertible securities. The 'best efforts' nature of the offering and the 'going concern' warning introduce high investment risk. Returns are dependent on share price appreciation as no dividends are planned.
• **Employees**: The company's operations in Israel expose employees to risks from geopolitical conflicts, including potential military service call-ups that could affect business continuity.
• **Customers/Partners**: Recent purchase orders and R&D collaborations (e.g., Bondor Foods, Wyler Farm, UMAMI Bioworks, Vegefarm, ITRI) indicate continued product development and market expansion, potentially benefiting these partners.
• **Creditors**: The 'going concern' warning suggests increased risk for creditors, as the company's ability to meet its obligations is in doubt without further capital.

Next Steps

• The registration statement needs to become effective for the proposed sale to the public to commence.
• The current public offering is expected to close on or before August 10, 2025.
• The company expects to deliver the securities to purchasers on or about the closing date.
• The company will continue to use net proceeds for working capital, business growth, and general corporate purposes.
• The potential acquisition of Twine Solutions Ltd. is subject to final due diligence, definitive agreements, and shareholder approval.
• The company is committed to making commercially reasonable efforts to keep the resale registration statement for the February 2025 private placement effective.
• The company has agreed to file one or more registration statements for the resale of securities from the June 2025 private placement and convertible loan within 90 calendar days, aiming for effectiveness by August 31, 2025.

Key Dates

Recommendation

Keywords

Foodtech, Alternative Protein, 3D Printing, Cultivated Meat, Plant-Based Food, SEC Filing, Public Offering, American Depositary Shares, Warrants, Nasdaq, Biotech, Israel